Back to Market返回行情

HSIC Henry Schein, Inc.

USHealthcare
$83.86+0.77%ClosedMarket Cap: $9.55B

As of 2026-07-09 16:00

Why HSIC matters now

Henry Schein, Inc. (HSIC) is a US stock in Healthcare. The latest InvestLog snapshot shows $83.86 with +0.77% on the session and $9.55B in market capitalization; recent performance reads 1-month +9.60% and YTD +5.74%.

The latest financial table shown here is Q1 2026, with revenue of $3.37B, net income of $107.0M, and EPS of $0.92. Investors can compare that operating picture with valuation signals such as P/E 21.72 and FCF yield 4.7%.

The latest indexable market news headline is "Is Henry Schein (HSIC) Stock Undervalued Right Now?" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Hold with a median target of $87.00; recent insider activity includes DANIEL WILLIAM K filing A-Award. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

21.72

PEG

10.59

P/B

2.81

P/S

0.68

EV/EBITDA

12.69

DCF Value

$80.79

FCF Yield

4.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

29.7%

Operating Margin

5.6%

Net Margin

3.0%

ROE

11.9%

ROA

3.5%

ROIC

6.2%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$3.37B$107.0M$0.92
Q4 2025$3.44B$101.0M$0.85
FY 2025$13.18B$398.0M$3.27
Q3 2025$3.34B$101.0M$0.84

Analyst Ratings

Consensus

Hold

Target (Consensus)

$87.43

Target (Median)

$87.00

Target Range

$64.00 - $100.00

Strong Buy: 4Buy: 5Hold: 7Sell: 1Strong Sell: 0
BTIGBuy
2026-06-11
UBSNeutral
2026-05-06
MizuhoNeutral
2026-05-06
Morgan StanleyUnderweight
2026-04-24
Evercore ISI GroupOutperform
2026-04-08

Trading Activity

Insider Trades

DANIEL WILLIAM Kdirector
Sell2026-06-15
Murphy Kelly Annofficer: SVP & General Counsel
Sell2026-05-28
Murphy Kelly Annofficer: SVP & General Counsel
Sell2026-05-28
Murphy Kelly Annofficer: SVP & General Counsel
Sell2026-05-28
Murphy Kelly Annofficer: SVP & General Counsel
Sell2026-05-28

Company Info

Sector

Healthcare

Industry

Medical - Distribution

Country

US

Exchange

Beta

0.82

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.